RESEARCH-USE BIOSIMILAR ANTIBODY
Farletuzumab
Monoclonal antibody · IgG1
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer.
TARGETFOLR1
YMonoclonal antibody
CATALOGSC-BS-542
CATALOG NUMBERSC-BS-542
MOLECULAR WEIGHTApprox. 145.36 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer.
Farletuzumab is a recombinant research-use antibody directed against FOLR1.